Advertisement.
Advertisement.
Advertisement.
Market Cap | 402.01B |
Volume | 703,609.00 |
52-Wk High | 1,451.00 |
52-Wk Low | 722.10 |
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Glenmark Pharmaceuticals Ltd. market cap is 402.01B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Glenmark Pharmaceuticals Ltd. 52 week high is 1,451.00 as of July 27, 2024.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Glenmark Pharmaceuticals Ltd. 52 week low is 722.10 as of July 27, 2024.
Glenmark Pharmaceuticals Ltd. stock price today is 1,443.60.
Glenmark Pharmaceuticals Ltd. stock price yesterday was 1,436.65.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Glenmark Pharmaceuticals Ltd.’s P/E ratio is -26.77.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Glenmark Pharmaceuticals Ltd. P/B ratio is 4.3098.
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Glenmark Pharmaceuticals Ltd.'s EBITDA is 20.58.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Glenmark Pharmaceuticals Ltd. 50-day moving average is 1,233.22.